Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses (Q40597338)
Jump to navigation
Jump to search
scientific article published on February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses |
scientific article published on February 2004 |
Statements
1 reference
Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses (English)
1 reference
Mark J Dobrzanski
1 reference
Joyce B Reome
1 reference
Joseph A Hollenbaugh
1 reference
Richard W Dutton
1 reference
1 February 2004
1 reference
1 reference
172
1 reference
3
1 reference
1380-1390
1 reference
Identifiers
1 reference
1 reference